Min YH - Search Results

1

Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study.

Kim YR, Kim SJ, Lee HS, Jeon S, Cho H, Chung H, Jang JE, Cheong JW, Min YH, Kim JS. Kim YR, et al. Among authors: min yh. Cancer Res Treat. 2022 Apr;54(2):613-620. doi: 10.4143/crt.2021.270. Epub 2021 Aug 5. Cancer Res Treat. 2022. PMID: 34352996 Free PMC article.

2

Primary lymphoma of the thyroid.

Hahn JS, Chung HC, Min YH, Ko YW, Park CS, Suh CO, Kim GE, Yang WI. Hahn JS, et al. Among authors: min yh. Yonsei Med J. 1995 Sep;36(4):315-21. doi: 10.3349/ymj.1995.36.4.315. Yonsei Med J. 1995. PMID: 7483674 Free article.

3

Eight-year experience of malignant lymphoma--survival and prognostic factors.

Hahn JS, Lee S, Chong SY, Min YH, Ko YW. Hahn JS, et al. Among authors: min yh. Yonsei Med J. 1997 Oct;38(5):270-84. doi: 10.3349/ymj.1997.38.5.270. Yonsei Med J. 1997. PMID: 9409190 Free article.

4

Transplantation of peripheral blood stem cells mobilized by intensified consolidation and granulocyte colony-stimulating factor in acute leukemia.

Min YH, Lee ST, Kim JS, Jang JH, Suh HC, Kim HO, Hahn JS, Ko YW. Min YH, et al. Yonsei Med J. 2001 Feb;42(1):65-73. doi: 10.3349/ymj.2001.42.1.65. Yonsei Med J. 2001. PMID: 11293503 Free article.

5

Long-term bone marrow culture-derived stromal fibroblasts as a potential target for gene therapy in acute myelogenous leukemia.

Min YH, Li GX, Jang JH, Suh HC, Kim JS, Cheong JW, Lee ST, Hahn JS, Ko YW. Min YH, et al. Leuk Res. 2002 Apr;26(4):369-76. doi: 10.1016/s0145-2126(01)00134-5. Leuk Res. 2002. PMID: 11839380

6

Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype.

Lee ST, Jang JH, Cheong JW, Kim JS, Maemg HY, Hahn JS, Ko YW, Min YH. Lee ST, et al. Among authors: min yh. Br J Haematol. 2002 Sep;118(4):1128-31. doi: 10.1046/j.1365-2141.2002.03767.x. Br J Haematol. 2002. PMID: 12199796 Free article.

7

Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome.

Cheong JW, Eom JI, Maeng HY, Lee ST, Hahn JS, Ko YW, Min YH. Cheong JW, et al. Among authors: min yh. Br J Haematol. 2003 Aug;122(3):454-6. doi: 10.1046/j.1365-2141.2003.04452.x. Br J Haematol. 2003. PMID: 12877673 Free article.

8

Constitutive phosphorylation of FKHR transcription factor as a prognostic variable in acute myeloid leukemia.

Cheong JW, Eom JI, Maeng HY, Lee ST, Hahn JS, Ko YW, Min YH. Cheong JW, et al. Among authors: min yh. Leuk Res. 2003 Dec;27(12):1159-62. doi: 10.1016/s0145-2126(03)00102-4. Leuk Res. 2003. PMID: 12921955

9

Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.

Cheong JW, Chong SY, Kim JY, Eom JI, Jeung HK, Maeng HY, Lee ST, Min YH. Cheong JW, et al. Among authors: min yh. Clin Cancer Res. 2003 Oct 15;9(13):5018-27. Clin Cancer Res. 2003. PMID: 14581377

10

Apicidin potentiates the imatinib-induced apoptosis of Bcr-Abl-positive human leukaemia cells by enhancing the activation of mitochondria-dependent caspase cascades.

Kim JS, Jeung HK, Cheong JW, Maeng H, Lee ST, Hahn JS, Ko YW, Min YH. Kim JS, et al. Among authors: min yh. Br J Haematol. 2004 Jan;124(2):166-78. doi: 10.1046/j.1365-2141.2003.04759.x. Br J Haematol. 2004. PMID: 14687026 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page